An expert, independent second opinion on more than 1,800 prescription drugs, over-the-counter medications, and supplements

[print friendlyprint friendly]

Recent postings to
Worst Pills, Best Pills Newsletter Articles

  View the entire December 2014 issue in PDF format

  • Pregabalin (LYRICA): OK for Certain Seizures, but Not Pain
    (December 2014)
    LYRICA is heavily promoted for treatment of chronic pain due to fibromyalgia and other conditions. Learn why Public Citizen’s Health Research Group advises against using the drug to treat these painful conditions.
  • Sunshine Law Exposes Vast Industry Payments to Physicians
    (December 2014)
    In his editor’s column, Dr. Michael Carome discusses the implications of data recently released by the federal government that reveals the staggering amount of money drug and medical device companies are paying doctors and teaching hospitals.
  • Restless Legs Syndrome: Overdiagnosed and Overtreated
    (December 2014)
    In this review of restless legs syndrome (RLS), we discuss the limitations of the available drug treatments for the disorder and the nondrug approaches that are the safest options for people with mild to moderate RLS symptoms.
  • Albiglutide (TANZEUM): Another Me-Too Drug for Type 2 Diabetes
    (December 2014)
    Read about the dangers posed by albiglutide, yet another new diabetes drug designated as Do Not Use by Public Citizen’s Health Research Group because it offers no unique benefits but does pose unique risks.
  • Adding NSAIDS or Aspirin to Anticoagulants Increases Bleeding Danger
    (December 2014)
    If you are one of the millions of patients in the U.S. who take blood thinners on a long-term basis to prevent potentially harmful clots in the heart, veins or arteries, read this article to learn why you should avoid taking NSAIDS or aspirin unless absolutely necessary.

  View the entire November 2014 issue in PDF format

  View the entire October 2014 issue in PDF format

  • Benzocaine Teething Gels Associated With Life-Threatening Condition
    (October 2014)
    Learn why benzocaine-containing gels and liquids should never be used to treat teething discomfort and about the actions Public Citizen’s Health Research Group has taken to end the use of these dangerous products in infants.
  • Generic Drugs: Don’t Let Appearances Fool You
    (October 2014)
    Stopping beneficial medications threatens patient health. In his monthly editor’s column, Dr. Michael Carome discusses an intriguing new study showing that patients are more likely to stop taking important medications when pharmacies substitute one generic version of a drug for another differing in shape or color.
  • Widely Used Prostate Cancer Treatment Not Beneficial for Most
    (October 2014)
    Many men with localized prostate cancer are being treated unnecessarily with a commonly used class of drugs. Find out which drugs are being overused.
  • Eszopiclone (LUNESTA): Too Dangerous at Any Dose
    (October 2014)
    The Food and Drug Administration’s recent recommendation to lower the starting dose of the insomnia drug eszopiclone is insufficient to address the drug’s dangers. Learn why Public Citizen’s Health Research Group continues to designate eszopiclone as Do Not Use.
  • Severe Allergic Reactions to Acne Treatments
    (October 2014)
    Many commonly used over-the-counter acne products pose a risk of serious allergic reactions in children and adults. This article provides information on how to minimize the risk when starting treatment with one of these products.

   View back issues January 2004 - present

Additional Information from Public Citizen
Copyright © 2014 Public Citizen's Health Research Group. All rights reserved.